Editorial: Autoantibodies in Kidney Diseases

Editorial: Autoantibodies in Kidney Diseases

Bibliographic Details
Main Authors:	Kevin J. Marchbank, Ashley Frazer-Abel, Marie-Agnes Dragon-Durey, Bradley P. Dixon
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Immunology
Subjects:	autoantibody (aAb) complement aHUS C3G lupus immune complex
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.591338/full

Similar Items

Pediatric Atypical Hemolytic Uremic Syndrome Advances
by: Rupesh Raina, et al.
Published: (2021-12-01)

Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality
by: Gianluigi Ardissino, et al.
Published: (2021-06-01)

Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation
by: Boyang Xu, et al.
Published: (2022-01-01)

Contribución de variantes funcionales y cuantitativas del Factor H y las proteínas FHRs (Factor H-Related proteins) del Complemento en patología renal
by: Irene Gómez Delgado, et al.
Published: (2022-05-01)

Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD
by: Edwin K. S. Wong, et al.
Published: (2021-01-01)

Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus
by: Lauren A. Vanderlinden, et al.
Published: (2022-06-01)

The Rationale of Complement Blockade of the MCP<sub>ggaac</sub> Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review
by: Daniel Turudic, et al.
Published: (2023-08-01)

Differential diagnosis of thrombotic microangiopathy in nephrology
by: T. Sakari Jokiranta, et al.
Published: (2017-10-01)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal OutcomesPlain Language Summary
by: Natalja Haninger-Vacariu, et al.
Published: (2023-07-01)

Extrarenal manifestations of complement mediated thrombotic microangiopathies
by: Johannes eHofer, et al.
Published: (2014-09-01)

Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein
by: Aleksandra Urban, et al.
Published: (2021-11-01)

Ockham’s razor defeated: about two atypical cases of hemolytic uremic syndrome
by: Chloe Schwarz, et al.
Published: (2020-07-01)

Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
by: Kata Kelen, et al.
Published: (2023-09-01)

An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry
by: Len Woodward, et al.
Published: (2016-11-01)

Autoantibodies Against C3b—Functional Consequences and Disease Relevance
by: Vasil V. Vasilev, et al.
Published: (2019-01-01)

Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation
by: Emma Diletta Stea, et al.
Published: (2022-11-01)

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with <i>MCP</i> Gene Mutation and Successful Eculizumab Treatment
by: Alex Domínguez-Vargas, et al.
Published: (2024-01-01)

A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration
by: Thomas M. Hallam, et al.
Published: (2022-12-01)

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome
by: Sara Gastoldi, et al.
Published: (2023-02-01)

Unexpected Findings in a Child with Atypical Hemolytic Uremic Syndrome: An Example of How Genomics Is Changing the Clinical Diagnostic Paradigm
by: Eleanor G. Seaby, et al.
Published: (2017-05-01)

Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?
by: Andrea Spasiano, et al.
Published: (2023-09-01)

Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report
by: A. Inkeri Lokki, et al.
Published: (2020-04-01)

A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
by: Shirley Pollack, et al.
Published: (2021-06-01)

Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
by: Martin Hausberg, et al.
Published: (2019-01-01)

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway
by: Marion Anliker-Ort, et al.
Published: (2020-12-01)

Compound Haplotype Variants in <i>CFH</i> and <i>CD46</i> Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)—A Series of Cases from a Single Family
by: Agnieszka Furmańczyk-Zawiska, et al.
Published: (2021-04-01)

Favorable course of previously undiagnosed Methylmalonic Aciduria with Homocystinuria (cblC type) presenting with pulmonary hypertension and aHUS in a young child: a case report
by: Luciano De Simone, et al.
Published: (2018-08-01)

Atypical Hemolytic Uremic Syndrome post Kidney Transplantation: Two Case Reports and Review of the Literature
by: Sami eAlasfar, et al.
Published: (2014-12-01)

Complement system part II: role in immunity
by: Nicolas S. Merle, et al.
Published: (2015-05-01)

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
by: Romy N. Bouwmeester, et al.
Published: (2021-01-01)

Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis
by: Maria Radanova, et al.
Published: (2022-08-01)

Editorial: Updates on the complement system in kidney diseases
by: Roberta Bulla, et al.
Published: (2023-04-01)

Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
by: Rupesh Raina, et al.
Published: (2022-08-01)

Hemophagocytic lymphohistiocytosis and thrombotic microangiopathy after parvovirus B19 infection and renal transplantation: a case report
by: C. J. Steffen, et al.
Published: (2021-10-01)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
by: Rossella Piras, et al.
Published: (2023-01-01)

IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production
by: Qingjun Pan, et al.
Published: (2020-06-01)

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus
by: Jessica S. Kleer, et al.
Published: (2022-01-01)

End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report
by: Mohammed Tawhari, et al.
Published: (2023-03-01)

Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients
by: Ainhoa Pérez-Díez, et al.
Published: (2024-04-01)

Gain of function mutant of complement factor B K323E mimics pathogenic C3NeF autoantibodies in convertase assays
by: Aleksandra Urban, et al.
Published: (2018-01-01)